retatrutide clinical trials safety efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 PDF) Efficacy and safety of

Jerusalem Artichokes: The Prebiotic Powerhouse Also called sunchokes, these knobby vegetables are incredibly rich in inulin, a prebiotic fiber that feeds beneficial gut bacteria

Medicare rules, drug approvals, and prices change often

Monitor closely: Weight, appetite, sideeffects, and bloodwork

When interpreted together with the findings of the STEP 4 withdrawal trial and STEP 1 off-treatment extension study, which both showed weight regain after semaglutide discontinuation (after 20 weeks treatment in STEP 4 and 68 weeks treatment in STEP 1) 23,24 , these results support the benefit of continued semaglutide treatment for sustained weight loss

muciniphila , induce GLP-1 secretion and improve glucose homeostasis in C57BL/6J mice fed a high-fat diet (HFD) through interaction with intercellular adhesion molecule 2 (Icam-2), which activates GPCR-like downstream signals

Gallbladder, Pancreatitis and Other Less Common Events Beyond gastrointestinal symptoms, several less frequent adverse events appear in the trial data at rates worth understanding neither dismissed nor overstated